Runswick, Sarah
AstraZeneca (United Kingdom) · Memorial Sloan Kettering Cancer Center · Jilin University · Chinese Academy of Medical Sciences & Peking Union Medical College · Seoul National University Hospital · University of Manchester · Gdańsk Medical University · University of Pennsylvania
2 papers on CoChatORCID 0009-0009-8895-3247
Most cited papers
- Verified
Olaparib for Metastatic Breast Cancer in Patients with a Germline BRCA Mutation
Robson, M., Im, S.-A., Senkus, E., Xu, B., Domchek, S. M., Masuda, N., Delaloge, S., Li, W., Tung, N., Armstrong, A., et al. (2017) · New England Journal of Medicine
PARP inhibition in cancer therapyBRCA gene mutations in cancer
Cited by 3,294
- Verified
Transcriptional Pathway Signatures Predict MEK Addiction and Response to Selumetinib (AZD6244)
Dry, J. R., Pavey, S., Pratilas, C. A., Harbron, C., Runswick, S., Hodgson, D., Chresta, C., McCormack, R., Byrne, N., Cockerill, M., et al. (2010) · Cancer Research
Melanoma and MAPK PathwaysProtein Kinase Regulation and GTPase Signaling
Cited by 262
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free